October 2, 2012Open Access

Biomarker Discovery in Non–Small Cell Lung Cancer: Integrating Gene Expression Profiling, Meta-analysis, and Tissue Microarray Validation

Key Points

Key points are not available for this paper at this time.

Abstract

Using a novel NSCLC cohort together with a meta-analysis validation approach, we have identified a set of single genes with independent prognostic impact. One of these genes, CADM1, was further established as an immunohistochemical marker with a potential application in clinical diagnostics.

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Botling et al. (Tue,) studied this question.

synapsesocial.com/papers/69dab4e037b5141e3ba3c3fd https://doi.org/https://doi.org/10.1158/1078-0432.ccr-12-1139

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Gene Expression-Based Prognostic Signatures in Lung Cancer: Ready for Clinical Use?2010 · 359 citations
2Functional Role of Cell Surface CUB Domain-Containing Protein 1 in Tumor Cell Dissemination2009 · 63 citations
3Gene expression profiling in breast cancer: classification, prognostication, and prediction2011 · 740 citations
4A 2-Mb Sequence-Ready Contig Map and a Novel Immunoglobulin Superfamily Gene IGSF4 in the LOH Region of Chromosome 11q23.21999 · 120 citations
5Chips to Bedside: Incorporation of Microarray Data into Clinical Practice2006 · 28 citations

Demander à l'IA

Bookmark

View Full Paper